Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: The significance of penetration in the ascitic fluid

International Journal of Antimicrobial Agents

Volumn 18, Issue 5, 2001, Pages 441-444

  Sambatakou, Helen ^a,b   Giamarellos Bourboulis, Evangelos J ^a   Galanakis, Nearchos ^c   Giamarellou, Helen ^a  

^a SISMANOGLIO HOSPITAL   (Greece)

^b G GENNIMATAS GENERAL HOSPITAL   (Greece)

^c Piraeus Hospital Ag Panteleimon   (Greece)

Author keywords

Ciprofloxacin; Fluoroquinolones; Ofloxacin; Urinary

Indexed keywords

CIPROFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

AGED; ARTICLE; ASCITES; ASCITES FLUID ANALYSIS; BACTERIAL PERITONITIS; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG PENETRATION; DRUG URINE LEVEL; FEMALE; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; URINALYSIS;

AGED; ANTI-INFECTIVE AGENTS; ASCITIC FLUID; BLOOD; FEMALE; FLUOROQUINOLONES; HUMANS; INJECTIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; URINE;

EID: 0035174942     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00441-1     Document Type: Article

References (15)

1. Bacterial infections in liver disease
2. Pharmacokinetics of fluoroquinolones in hepatic failure
3. Urinary excretion and bactericidal activity of intravenous ciprofloxacin compared with oral ciprofloxacin
4. Quinolone pharmacokinetics and metabolism
5. Comparing the means of several groups
6. Spontaneous bacterial peritonitis: Prevention and therapy
7. The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin
8. Pharmacokinetics of ciprofloxacin in liver cirrhosis
9. Pharmacokinetic profiles of high-dose intravenous ciprofloxacin in severe sepsis
10. The pharmacokinetics of intravenous ciprofloxacin 400mg 12 hourly in patients with severe sepsis: The effect of renal function and intrabdominal disease
11. Concentrations of pefloxacin in plasma and tissue after administration as surgical prophylaxis
12. Urinary excetion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers
13. Pharmacokinetics of lomefloxacin in patients with cirrhosis
14. Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit
15. Population pharmacokinetics of ciprofloxacin in patients with liver impairments analyzed by NPEM2 algorithm - A retrospective study